Research.Patient.info
Erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD) research hub
2 indexed studies · 2 currently recruiting
- recruitingTherapeutic confirmatory (Phase III)
A randomized, phase 3, double-blind, double-dummy, active comparator-controlled multicenter study to evaluate the efficacy and safety of 2 doses of linaprazan glurate compared to lansoprazole in 4 or 8 weeks healing in participants with erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD) of Los Angeles (LA) grades A to D
This study tests a new medicine called linaprazan glurate for severe acid reflux. Researchers want to see if it heals damage in the food pipe better than lansoprazole, a standard NHS treatment. It compares how well both medicines soothe heartburn and repair the lining of the gullet over 8 weeks.
Germany · Poland · Hungary - recruitingTherapeutic confirmatory (Phase III)
A randomized, phase 3, double-blind, double-dummy, active comparator-controlled multicenter clinical trial to evaluate the efficacy and safety of linaprazan glurate compared to lansoprazole in maintenance of healing in participants with healed erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD) of Los Angeles (LA) grades A to D
This study is testing a new medicine, linaprazan glurate, against an existing one, lansoprazole, to see how well they keep healed acid reflux (erosive esophagitis) from coming back. It involves adults with a history of this condition.
Hungary · Germany · Romania